|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Improving Conventional or Low Dose Metronomic Chemotherapy with Targeted Antiangiogenic Drugs
Robert S. Kerbel
Cancer Res Treat.
2007;39(4):150-159. Published online December 31, 2007 DOI:
https://doi.org/10.4143/crt.2007.39.4.150
Crossref 37
Pilot Study of Heptaplatin,
UFT
-E and Leucovorin in Advanced Gastric Carcinoma
Sang Cheul Oh, So Young Yoon, Jae Hong Seo, Chul Won Choi, Byung Soo Kim, Sang Won Shin, Yeul Hong Kim, Si Young Kim, Hwi Joong Yoon, Kyung Sam Cho, Jun Suk Kim
Cancer Res Treat.
2003;35(2):117-122. Published online April 30, 2003 DOI:
https://doi.org/10.4143/crt.2003.35.2.117
Crossref 4
Phase II Trial of Gemcitabine,
UFT
-E, Leucovorin Combination Chemotherapy in Advanced Pancreatic Adenocarcinoma
So Young Yoon, Kyong Hwa Park, Sang Chul Oh, Jae Hong Seo, Chul Won Choi, Byung Soo Kim, Jae Seon Kim, Chang Duck Kim, Sang Won Shin, Yeul Hong Kim, Jun Suk Kim
Cancer Res Treat.
2002;34(2):111-116. Published online April 30, 2002 DOI:
https://doi.org/10.4143/crt.2002.34.2.111
Crossref 1
A Phase II Trial of
UFT
-E and Oral Leucovorin in Advanced Colorectal Cancer
Won Sup Lee, Keun Seok Lee, Ki Hyun Kim, Baek Yeol Ryoo, Won Seog Kim, Won Ki Kang, Yoon Koo Kang, Dae Seog Heo, Yung Jue Bang, Noe Kyeong Kim
Cancer Res Treat.
2001;33(3):225-228. Published online June 30, 2001 DOI:
https://doi.org/10.4143/crt.2001.33.3.225
Treatment of Advanced Gastric Cancer with Oral
UFT
and Leucovorin
Seong Kyoon Cheong, Ki Chan Kim, Yeul Hong Kim, Sang Won Shin, Jun Suk Kim
J Korean Cancer Assoc.
1994;26(3):369-377.
1
Journal Impact Factor 4.6